Internal Medicine, Medical Oncology · Germantown, TN
NPI
1730403072
Since 2010
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
7945 Wolf River Blvd
Germantown, TN, 38138
Phone (901) 683-0055
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.6M
144,187 services
Medicare patients, 2024
768
Average age 74
Drug cost, 2024
$4.2M
2,121 prescriptions
Company payments, 2025
$88K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gregory Vidal was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 12,160 times for 33 patients. In total Gregory Vidal billed 144,187 services in 202 codes, and Medicare paid $2.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-11-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 12,160 | 33 | $2.32 | $28K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 11,000 | 28 | $44.85 | $493K |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 9,750 | 13 | $0.87 | $8,481 |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 9,700 | 15 | $0.06 | $557 |
| J9267 Injection, paclitaxel, 1 mg | Office | 5,322 | 17 | $0.08 | $418 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 4,320 | 12 | $39.96 | $173K |
| J0897 Injection, denosumab, 1 mg | Office | 3,960 | 30 | $19.83 | $79K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,296 | 112 | $0.09 | $294 |
| Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | Office | 2,930 | 14 | $20.84 | $61K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 2,112 | 13 | $19.34 | $41K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 850 | 38 | $0.74 | $631 |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 725 | 20 | $3.57 | $2,590 |
| 85025 Blood Count | Office | 632 | 209 | $7.56 | $4,781 |
| 80048 Clinical Chemistry | Office | 608 | 206 | $8.24 | $5,009 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 607 | 22 | $0.22 | $136 |
By year: 2022 $357K for 18,911 services; 2023 $668K for 33,825 services; 2024 $2.6M for 144,187 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 632 | 209 | $7.56 | $4,781 |
| 80048 Clinical Chemistry | 608 | 206 | $8.24 | $5,009 |
| 80076 Clinical Chemistry | 519 | 185 | $7.95 | $4,127 |
| 36415 Venipuncture Blood Collection | 469 | 189 | $8.60 | $4,033 |
| 82565 Clinical Chemistry | 46 | 32 | $4.91 | $226 |
| 84443 Clinical Chemistry | 41 | 15 | $16.46 | $675 |
| 85610 Clinical Chemistry | 19 | 13 | $4.20 | $79.8 |
| 82728 Clinical Chemistry | 16 | 13 | $13.36 | $214 |
| 83550 Clinical Chemistry | 15 | 12 | $8.57 | $129 |
| 83540 Clinical Chemistry | 15 | 12 | $6.34 | $95.1 |
Medicare prescription drug claims, 2024
In 2024, the drug Gregory Vidal prescribed most often to Medicare patients was Anastrozole, with 463 prescriptions and refills. In total Gregory Vidal wrote 2,121 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 463 | 1,237 | 149 | $11K |
| Letrozole Generic | 247 | 678 | 79 | $6,391 |
| Tamoxifen Citrate Generic | 209 | 533 | 71 | $5,778 |
| Verzenio Abemaciclib | 125 | 125 | 22 | $1.9M |
| Ibrance Palbociclib | 95 | 95 | 13 | $1.5M |
| Exemestane Generic | 92 | 209 | 28 | $17K |
| Potassium Chloride Generic | 69 | 90 | 18 | $927 |
| Gabapentin Generic | 61 | 63 | 14 | $406 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 57 | 57 | 21 | $1,219 |
| Ondansetron Hcl Generic | 54 | 56 | 30 | $2,098 |
| Oxybutynin Chloride Generic | 37 | 65 | 11 | $506 |
| Olanzapine Generic | 31 | 50 | 15 | $309 |
| Dexamethasone Generic | 29 | 30 | 15 | $641 |
| Zolpidem Tartrate Generic | 28 | 28 | Under 11 | $176 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 27 | 27 | Under 11 | $860 |
Brand drugs: 371 claims; generic drugs: 1,750 claims; opioid claims: 94.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gregory Vidal $88K ($80K in general payments such as food, travel and fees and $8,123 for research) from 20 companies. The largest payer was Gilead Sciences, Inc. with $21K.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 38 | $21K |
| AstraZeneca Pharmaceuticals LP AZN | 16 | $16K |
| Genentech, Inc. ROG.SW | 13 | $12K |
| Novartis Pharmaceuticals Corporation NVS | 18 | $9,992 |
| Eli Lilly and Company LLY | 3 | $8,400 |
| F. Hoffmann-La Roche AG ROG.SW | 5 | $8,123 |
| TerSera Therapeutics LLC | 10 | $4,784 |
| Lilly USA, LLC LLY | 1 | $2,400 |
| Pfizer Inc. PFE | 3 | $2,313 |
| AstraZeneca UK Limited AZN | 1 | $1,995 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.